Breast Cancer Clinical Trial
Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)
Summary
The purpose of this study is to create a registry to evaluate the use of intra-operative radiation therapy (IORT) and to study the efficacy and toxicity of breast radiotherapy given intra-operatively as a single fraction after breast conserving surgery,
Full Description
A registry trial has been designed and modeled after the original successful TARGIT protocol, to continue the use of IORT for a select population of women, and to follow outcomes with regards to local and regional control, toxicity and morbidity. Patients selected for breast conserving surgery, who are considered to have a low risk of local recurrence, are eligible for this registry trial once their informed consent is obtained. This single arm cohort study allows entry of patients who have been diagnosed with early stage breast cancer and whose clinical stage is suitable for treating conservatively (small tumor and no gross nodal involvement). Tumors should not be more than 3.5 cm in size.
Eligibility Criteria
Inclusion Criteria:
Female
Age 45 or greater
Diagnosed with operable invasive breast cancer, T1 and T2 (< 3.5 cm), N0, M0, confirmed by cytological or histological examination
Suited for breast conserving surgery
Have had an ipsilateral (same side as current cancer) diagnostic mammogram within 12 months of enrollment
Exclusion Criteria:
age 44 or less
Axillary lymph node positive breast cancer
Invasive lobular cancer
Tumor size > 3.5 cm
Extensive Intraductal Component (EIC= > 25% of the lumpectomy specimen involved with ductal carcinoma in situ, DCIS) as assessed on surgical pathologic lumpectomy specimen
Multicentric cancer in the same breast not amenable to excision with a single lumpectomy
Inability to assess pathologic margin status
Synchronous bilateral breast cancer at the time of diagnosis.
Ipsilateral breast had a previous cancer and/or prior in-field radiation.
Patients known to have BRCA1/2 gene mutations
Neoadjuvant treatment (hormones or chemotherapy)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Cincinnati Ohio, 45242, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.